{"url_path":"/sec/sabsw/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1833214/0001193125-26-218195-index.html","accession_number":"0001193125-26-218195","cik":"0001833214","ticker":"SABS","issuer_name":"SAB Biotherapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1833214/0001193125-26-218195-index.html","primary_entity_key":"0001833214","primary_entity_name":"SAB Biotherapeutics, Inc."},"word_count":67,"has_tables":true,"body_markdown":"## Item 1A. Risk Factors.\n\nOur business is subject to various risks, including those described in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on March 9, 2026, which we strongly encourage you to review (the “2025 Annual Report”). There have been no material changes from the risk factors described in our 2025 Annual Report."}